PIK3CA and breast carcinoma: The phosphoinositide 3-kinase (PI3K)-protein kinase B (AKT) pathway is active in most breast cancers, and 40% of ER+ breast cancers are associated with PIK3CA mutation, which is a common genomic alteration in breast cancer [4].